Adam Grippin and Christiano Marconi write about the potential of COVID-19 mRNA-based vaccines being used for cancer treatments.
Adam Grippin
Adam Grippin is a physician scientist specializing in cancer immunotherapy at the MD Anderson Cancer Center at the University of Texas. He completed his medical and doctoral training at the University of Florida, where he developed a personalized mRNA-nanoparticle platform that is currently in first-in-human clinical trials for treatment of brain tumors.